What research on psychedelic microdosing says about focus, mood, and mental performance

Written by

Pleun

Microdosing has, in recent years, shifted from a niche experiment to a serious area of research within both science and performance-driven environments. But what does that research actually show? In this article, we look at recent findings by James Fadiman and Sophia Korb, which shed new light on the effects of microdosing with psychedelics such as psilocybin – the active compound in truffles.

How has microdosing with psilocybin been studied?

Microdosing involves taking a very low, sub-perceptual dose of a substance such as psilocybin. In practical terms, this means no hallucinations, no “trip,” and no loss of control. In this study, the dosage was around 0.4 grams of dried mushrooms. What users report is more subtle: increased focus, less mental noise, and a stronger sense of direction – without it becoming overwhelming. These effects were explored in a large-scale real-world study, in which more than 1,000 participants from 59 countries tracked their experiences.

Participants followed a fixed rhythm of one day of dosing followed by two rest days (the beginner protocol used by Fungki), and reported daily on their mood, behavior, and overall experience over a period of weeks to months. This makes the study fundamentally different from traditional laboratory research. It was not conducted in a sterile or isolated environment, but rather embedded in everyday life-where focus, work, and mental performance actually take place.

Key findings of psilocybin microdosing

Improved mood and reduced anxiety
The most consistent finding was a decrease in depressive feelings, reduced anxiety, and an increase in positive emotions. For many participants, this didn’t mean feeling extremely happy, but rather more stable and calm. And that is often where real performance begins.
Increased focus and less procrastination
One of the most notable insights was reduced procrastination, improved concentration, and greater mental clarity. Some participants even used microdosing as an alternative to ADHD medication-although this is not medical advice and should be approached with caution. What stands out: users did not report the typical “crash” often associated with stimulant-based medications such as Ritalin or Adderall. A commonly described experience was: “You feel productive, able to focus on what you choose, enjoy your relationships, have steady energy, and don’t even notice that you’ve taken anything.”
Creativity and problem-solving
Participants reported seeing connections more quickly, generating ideas more easily, and thinking more flexibly. This aligns with earlier research on neuroplasticity and cognitive flexibility. It’s not necessarily about having more ideas- but having better access to the ideas that are already there.
Effects on physical symptoms
Although less central to the study, there are indications that microdosing may help with conditions such as migraines, chronic pain, and PMS-related symptoms. One notable example described a participant with chronic back pain who experienced the pain signal shifting into a light, tingling sensation. Important: these are individual reports, not clinically proven medical effects.
Social and behavioral changes
Beyond internal effects, participants also reported increased patience, greater openness, and improved interactions with others. Interestingly, some also noticed better health-related habits, such as improved nutrition and sleep. This suggests that microdosing may not only influence how you think, but also how you act.

You feel productive, able to focus on what you choose, enjoy your relationships, have steady energy, and don’t even notice that you’ve taken anything.

The importance of the microdosing protocol

A crucial part of the research is the rhythm:

Day 1: dose
Day 2: effect day
Day 3: reset

This highlights something important: the effects are not just in the dose itself, but in the alternation. The rest days are not a pause – they are part of the system. This aligns directly with how we approach mental performance at Fungki: not as a peak, but as a rhythm. This exact rhythm forms the foundation of the Fungki beginner protocol. Instead of taking isolated microdoses, you follow a structured pattern in which activation and recovery alternate. Not to stay constantly on, but to give your brain the space to respond, process, and adapt. That’s where the difference lies. Not in taking more, but in timing it better. And it’s within this rhythm that many people find what they’re actually looking for: greater clarity, without overload.

What does this microdosing research mean for you?

This research highlights something often missing from the conversation: microdosing is not a shortcut – it’s a context enhancer. What you already do – thinking, working, creating – can become sharper, but only when there is structure underneath it. That’s where the difference lies. And that’s exactly where the shift from experimenting to training begins.

Where this research stops at observation, Fungki takes it a step further. Not through isolated microdoses or without direction, but through a structured protocol built on rhythm. Not constant activation, but a deliberate alternation between activation and recovery – designed for mental performance in everyday life.

The truffles are the catalyst.
The protocol is the system.

Safety and considerations

The research is promising, but not without limitations. It is based on self-reported data (without a control group), meaning placebo effects may play a role. In addition, around 20% of participants reported neutral or negative experiences. The most commonly reported side effects of psilocybin were mild anxiety and physical discomfort (such as stomach sensitivity). Because of this, we generally recommend having breakfast before taking a dose and avoiding chewing the truffles, as this may help reduce potential discomfort.